Personal profile
Related documents
Education/Academic qualification
Master of Business Administration in Healthcare, The International university of health and welfare
Doctor of Medical Science, 帝京大学アジア国際感染症制御研究所・兼担教授
External positions
Associate Professor, School of Medicine, Teikyo University
Feb 2024 → …
病院准教授, School of Medicine, Teikyo University
Feb 2022 → Jan 2024
講師, School of Medicine, Teikyo University
Apr 2019 → Jan 2022
School of Medicine, Teikyo University
Oct 2014 → Mar 2019
助教, The University of Tokyo Hospital
Apr 2013 → Sep 2014
The University of Tokyo Hospital
Apr 2009 → Mar 2013
The University of Tokyo Hospital
Jul 2006 → Mar 2009
The University of Tokyo Hospital
Jul 2005 → Jun 2006
The University of Tokyo Hospital
Apr 2002 → Jun 2005
The University of Tokyo Hospital
Apr 2001 → Mar 2002
The University of Tokyo Hospital
Apr 2000 → Mar 2001
Research Fields
- Urology
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Multiple Cranial Neuropathies After Lenvatinib–Pembrolizumab Therapy for Metastatic Renal Cell Carcinoma: A Case Report
Minagawa, H., Kaneko, T., Hokkoku, K., Miyashima, A., Hazuki, I., Tenei, O., Yagi, R., Kishitani, K., Takei, K. & Nakagawa, T., Jan 2026, In: IJU Case Reports. 9, 1, e70136.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma
Japanese Urological Oncology Group, Jun 2025, In: Clinical Genitourinary Cancer. 23, 3, 102322.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study
Honda, K., Kawai, T., Taguchi, S., Shiratori, T., Miyakawa, J., Nakamura, Y., Kaneko, T., Suzuki, K., Suda, S., Kamei, J., Kakutani, S., Niimi, A., Yamada, Y., Urakami, S., Fukuhara, H., Nakagawa, T. & Kume, H., Nov 2025, In: International Journal of Urology. 32, 11, p. 1593-1601 9 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan
the Japan Urological Oncology Group, Oct 2025, In: International Journal of Clinical Oncology. 30, 10, p. 2079-2086 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinoma
Kawai, T., Kurokawa, Y., Taguchi, S., Honda, K., Maki, K., Ambe, Y., Saegusa, N., Yamamoto, M., Miyakawa, J., Tokura, Y., Inoue, H., Tanaka, T., Nara, K., Kaneko, T., Fujii, Y., Kamei, J., Kakutani, S., Yamada, Y., Niimi, A. & Yamada, D. & 3 others, , 1 Apr 2025, In: Japanese Journal of Clinical Oncology. 55, 4, p. 421-427 7 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations